Publicaciones (22) Publicaciones de Luis Antonio Mariñas Pardo

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  2. Preliminary Investigation on Efficacy and Safety of Substance P-Coated Stent for Promoting Re-Endothelialization: A Porcine Coronary Artery Restenosis Model

    Tissue Engineering and Regenerative Medicine, Vol. 21, Núm. 1, pp. 53-64

2022

  1. Rare Variants in Genes of the Cholesterol Pathway Are Present in 60% of Patients with Acute Myocardial Infarction

    International Journal of Molecular Sciences, Vol. 23, Núm. 24

2021

  1. Systemic treatment of immune-mediated keratoconjunctivitis sicca with allogeneic stem cells improves the schirmer tear test score in a canine spontaneous model of disease

    Journal of Clinical Medicine, Vol. 10, Núm. 24

2020

  1. Airway hyperresponsiveness, inflammation, and pulmonary emphysema in rodent models designed to mimic exposure to fuel oil–derived volatile organic compounds encountered during an experimental oil spill

    Environmental Health Perspectives, Vol. 128, Núm. 2

2019

  1. Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis

    Lung, Vol. 197, Núm. 4, pp. 523-531

2018

  1. Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: Clinical efficacy and safety

    Veterinary Record, Vol. 183, Núm. 21, pp. 654

  2. Allogeneic adipose-derived mesenchymal stem cells (Horse Allo 20) for the treatment of osteoarthritis-associated lameness in horses: Characterization, safety, and efficacy of intra-articular treatment

    Stem Cells and Development, Vol. 27, Núm. 17, pp. 1147-1160

2017

  1. Macrophagic enhancement in optical coherence tomography imaging by means of superparamagnetic iron oxide nanoparticles

    Cardiology Journal, Vol. 24, Núm. 5, pp. 459-466

2015

  1. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes

    Veterinary Journal, Vol. 206, Núm. 3, pp. 385-390

  2. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes

    Veterinary Journal, Vol. 206, Núm. 3, pp. 391-397

2014

  1. Dopamine mobilizes mesenchymal progenitor cells through d2-class receptors and their pi3k/akt pathway

    Stem Cells, Vol. 32, Núm. 9, pp. 2529-2538

  2. Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 69, Núm. 6, pp. 730-740

  3. Uso de células progenitoras mesenquimales alogénicas en patologías ortopédicas en caballos

    Equinus: Medicina y cirugía equina, Núm. 39, pp. 48-60

2012

  1. Determination of ELISA reproducibility to detect protein markers in exhaled breath condensate

    Journal of Breath Research, Vol. 6, Núm. 4

  2. Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients

    International Journal of Molecular Medicine, Vol. 30, Núm. 2, pp. 365-373

  3. Estudio de tres técnicas de concentración de proteína para la determinación del perfil proteico en Condensado de Aire Exhalado

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 108-108

  4. In vivo genotoxicity assessment in rats exposed to prestige-like oil by inhalation

    Journal of Toxicology and Environmental Health - Part A: Current Issues

2011

  1. Mesenchymal niches of bone marrow in cancer

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 611-616

2009

  1. Inflamación y reparación

    Enfermedades respiratorias (Grupo Aula Médica S.L.), pp. 11-26